等待开盘 02-05 09:30:00 美东时间
-0.170
-1.20%
Bank of America Securities’ analysts highlighted 13 companies within the Russell 2000 (IWM) that offer more than 20% expected long-term growth with non-stretched valuations. Stocks within the Russell ...
2025-12-22 23:49
今日重点评级关注:Ascendiant Capital:维持Society Pass"买入"评级,目标价从22美元升至22.5美元;HC Wainwright & Co.:维持Climb Bio"买入"评级,目标价从9美元升至11美元
2025-12-19 10:15
Mizuho analyst Ann Hynes maintains Surgery Partners (NASDAQ:SGRY) with a Outperform and lowers the price target from $22 to $19.
2025-12-18 21:16
Surgery Partners (SGRY) said that its wholly-owned subsidiary, Surgery Center Holdings priced $425M aggregate principal amount of its 7.250% senior unsecured notes due 2032. The offering is expected t...
2025-12-12 17:00
Surgery Partners announced plans to offer an additional $425 million in 7.25% senior unsecured notes due 2032. The notes will be part of the same series as those issued in April 2024 and will be guaranteed by the Issuer's domestic subsidiaries. Proceeds will be used for general corporate purposes, including repaying borrowings under the revolving credit facility. The offering is targeted at qualified institutional buyers in the U.S. and non-U.S. ...
2025-12-11 13:23
Surgery Partners, Inc. (NASDAQ:SGRY) announces a new partnership with Baylor Scott & White Health, the largest not-for-profit health system in Texas, to jointly own with physicians the 16-bed hospital in Bryan known
2025-12-09 01:02
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从4美元升至9美元;BTIG:维持Cullinan Therapeutics"买入"评级,目标价从32美元升至38美元
2025-11-25 10:27
今日重点评级关注:Canaccord Genuity:维持Fractyl Health"买入"评级,目标价从6美元升至8美元;HC Wainwright & Co.:维持MediWound"买入"评级,目标价从31美元升至36美元
2025-11-24 11:23
今日重点评级关注:HC Wainwright & Co.:维持Oncolytics Biotech"买入"评级,目标价从5美元升至10美元;HC Wainwright & Co.:维持Barinthus Biotherapeutics"买入"评级,目标价从3美元升至4美元
2025-11-18 15:28
Mizuho analyst Ann Hynes maintains Surgery Partners (NASDAQ:SGRY) with a Outperform and lowers the price target from $28 to $22.
2025-11-18 01:40